Daniel L. Goodwin’s Bristol-Myers Squibb BMY Stock Holding History

Daniel L. Goodwin’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-500	Closed	-$26K	–	112
2014 Q1	$26K	Buy	+500	New	+$26.6K	﹤0.01%	117

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Daniel L. Goodwin's BMY Position: Q2 2014 in Review

Daniel L. Goodwin sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 500 shares — an estimated $26K sold.

Daniel L. Goodwin first reported a position in BMY in Q1 2014 and held it in 1 quarter. The position peaked at $26K in Q1 2014. 1,301 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Daniel L. Goodwin reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
Daniel L. Goodwin sold 500 Bristol-Myers Squibb shares in Q2 2014, an estimated $26K.
Daniel L. Goodwin first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 1 quarter.
Daniel L. Goodwin's Bristol-Myers Squibb position peaked at $26K in Q1 2014.
1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Daniel L. Goodwin's 13F filing for Q2 2014, filed 14 Aug 2014.